FEATURE ARTICLES

The QIAsymphony AS from Qiagen has extended the company’s range of high-quality assay and detection solutions. This new module in the QIAsymphony series provides fully automated set up of Qiagen assays and polymerase chain reaction PCR kits and combines its experience in sample and assay technologies on a single platform.

In sub-Saharan Africa, turnaround time for CD4 lymphocyte count results is an important but often missing factor in the use and monitoring of effective antiviral therapy, as Grace Kahenya explains.

Increased demand for sexually transmitted disease testing as a result of the implementation of national screening programmes can now be accommodated thanks to a new, fully automated molecular biology instrument from Roche.

In December 2009, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) published a standardised European disc-diffusion test method. Amanda Appleton liaised closely with the EUCAST committee during this time and, here, explains what this means for laboratories across Europe.

Feather disposable microtome blades have a reputation for high quality and now represent the global gold standard in microtomy. Here, Sue Wollington talks about history, production and how users can get the best performance from their disposable blades.

Despite launch of the National Chlamydia Screening Programme in 2003, levels of testing in the high-risk group are not sufficiently high to reduce the prevalence of this infection. Here, Rachel Adams considers the problem and how the latest sampling technology can help.

The recent joint meeting of UK NEQAS (BTLP) and the BBTS Blood Bank Technology SIG provided transfusion professionals with an opportunity to examine their role in improving clinical outcomes in the wider healthcare community. Pathology in Practice reports.

A public-private collaboration between the Royal Brompton & Harefield NHS Foundation Trust and Beckman Coulter has provided value for money and a quality of service second to none. The Royal Brompton & Harefield NHS Foundation Trust comprises two specialist hospitals that provide treatment for people with heart and lung disease. They are recognised worldwide for their expertise, standard of care and research success. Health and social care regulator the Care Quality Commission recently awarded the trust the highest possible rating of ‘excellent’ for its “exceptional performance and innovation”.

A recent seminar organised by Sebia UK highlighted current trends in electrophoresis testing and examined its clinical utility in specific diagnostic applications. The event brought together clinical specialists, industry experts and biomedical scientists at historic Royal Holloway, University of London.

Plasma viscosity testing emerged in the early 1970s following pioneering work by Jock Harkness in Taunton. Now, the haematology at Musgrove Park boasts the very latest in viscosity instrumentation.

A cutting-edge imaging system is being used in Manchester to investigate the links between structure and function in mammalian cells, and, in particular, the regulation of cell division.

The Analyser Monitoring Programme, managed by the Guildford Medical device Evaluation Centre, has been growing steadily since 2005, and provides UK laboratories with invaluable information to aid major analyser purchasing decisions.

Following Thermo Fisher Scientific’s recent acquisition of histopathology supplies manufacturer Raymond A Lamb, Pathology in Practice took the opportunity to talk with Giulio Cerroni about his experiences and views of the anatomical pathology market and the company’s latest innovations and investments.

Three laboratories in the United Kingdom recently took delivery of the new cobas 8000 series modular analyser from Roche. Here, biomedical scientists in Bristol, Gateshead and Poole give their views on the latest serum work area technology.

Sample collection is an important if underappreciated aspect of the battle against hospital-acquired infection. Here, Alison Smith looks at the latest innovations in swab technology.

An evaluation of the Quo-Test A1c point-of-care assay was carried out in the biochemistry department of the John Radcliffe Hospital in Oxford by an independent evaluator. Tim James and Paul Sharpe provide an overview.

Many laboratories routinely test for extended-spectrum beta-lactamases but not for AmpC resistance mechanisms. A simple diagnostic test is now available for the latter, and here Sally Cocks and Carmel Vaughan report on early validation trials.

Speaking to Pathology in Practice at the IBMS Biomedical Science Congress in September, Beckman Coulter’s new marketing manager Leanne Annereau explained how the integration of Olympus Diagnostics is progressing.

Recently, Mark Reed succeeded Jag Grewal as chairman of the IBMS Company Members Committee. Here, he explains the role of the committee and his vision for the future.

Lauren Young explains how the Institute of Cell and Molecular Science has utilised sample-tracking software in order to improve productivity and organise the ICMS freezer facilities.